Disruption of protein–protein interactions: Towards new targets for chemotherapy

Live or let die: the cell's response to p53

Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,177 · see citing works

Signaling Through Scaffold, Anchoring, and Adaptor Proteins

Pawson, T., & Scott, J. D. (1997) · Science · doi:10.1126/science.278.5346.2075 · Cited by 2,256 · see citing works

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914 · see citing works

The p53-mdm-2 autoregulatory feedback loop.

Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801 · see citing works

Dimerization of cell surface receptors in signal transduction

Heldin, C.-H. (1995) · Cell · doi:10.1016/0092-8674(95)90404-2 · Cited by 1,634 · see citing works

Structure of Bcl-x _L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis

Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., et al. (1997) · Science · doi:10.1126/science.275.5302.983 · Cited by 1,476 · see citing works

Apoptosis Signaling

Strasser, A., O’Connor, L., & Dixit, V. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.217 · Cited by 1,369 · see citing works

Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells

Wang, J., Liu, D., Zhang, Z., Shan, S., Han, X., Srinivasula, S. M., Croce, C. M., Alnemri, E. S., & Huang, Z. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7124 · Cited by 1,201 · see citing works

Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 Protease

Wlodawer, A., Miller, M., Jaskólski, M., Sathyanarayana, B. K., Baldwin, E. T., Weber, I. T., Selk, L., Clawson, L., Schneider, J., & Kent, S. B. H. (1989) · Science · doi:10.1126/science.2548279 · Cited by 1,167 · see citing works

Online Mendelian Inheritance In Man (OMIM)

Hamosh, A., Scott, A. F., Amberger, J. S., Valle, D. L., & McKusick, V. A. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1 · Cited by 1,160 · see citing works

The biology of erbB-2/nue/HER-2 and its role in cancer

Hynes, N. E. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90012-4 · Cited by 974 · see citing works

The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease

Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862 · see citing works

A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation

Hébert, T. E., Moffett, S., Morello, J.-P., Loisel, T. P., Bichet, D. G., Barret, C., & Bouvier, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16384 · Cited by 775 · see citing works

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 752 · see citing works

Convergent Solutions to Binding at a Protein-Protein Interface

DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 673 · see citing works

Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle

Jordan, A. M., Hadfield, J. A., Lawrence, N. J., & McGown, A. T. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4 · Cited by 671 · see citing works

Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

Liu, Z., Sun, C. C., Olejniczak, E. T., Meadows, R. P., Betz, S. F., Oost, T. K., Herrmann, J. E., Wu, J. C., & Fesik, S. W. (2000) · Nature · doi:10.1038/35050006 · Cited by 647 · see citing works

Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.

Tamm, I., Kornblau, S. M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D. A., Tudor, G., Qui, Y. H., Monks, A. P., et al. (2000) · PubMed · Cited by 610 · see citing works

Insights from the study of animals lacking functional estrogen receptor

Korach, K. S. (1994) · Science · doi:10.1126/science.7985022 · Cited by 580 · see citing works

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

Degterev, A., Lugovskoy, A. A., Cardone, M. H., Mulley, B., Wagner, G., Mitchison, T. J., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550 · see citing works

PATHOLOGIC CONFORMATIONS OF PRION PROTEINS

Cohen, F. E., & Prusiner, S. B. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.793 · Cited by 539 · see citing works

The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase.

Koch, W. J., Inglese, J., Stone, W. C., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53090-8 · Cited by 475 · see citing works

Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3

Tzung, S.-P., Kim, K. M., Basañez, G., Giedt, C. D., Simon, J., Zimmerberg, J., Zhang, K. Y. J., & Hockenbery, D. M. (2001) · Nature Cell Biology · doi:10.1038/35055095 · Cited by 452 · see citing works

Protein folding: local structures, domains, subunits, and assemblies

Jaenicke, R. (1991) · Biochemistry · doi:10.1021/bi00227a001 · Cited by 440 · see citing works

Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding

Chen, J. C.-H., Krucinski, J., Miercke, L. J. W., Finer-Moore, J. S., Tang, A. H., Leavitt, A. D., & Stroud, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150220297 · Cited by 404 · see citing works

Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII-binding domain.

Carr, D. W., Hausken, Z. E., Fraser, I. D. C., Stofko, R. E., & Scott, J. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42221-1 · Cited by 346 · see citing works

Assembly and morphology of HIV

Gelderblom, H. R. (1991) · AIDS · doi:10.1097/00002030-199106000-00001 · Cited by 328 · see citing works

Toward Proteomimetics: Terphenyl Derivatives as Structural and Functional Mimics of Extended Regions of an α-Helix

Orner, B. P., Ernst, J. T., & Hamilton, A. D. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0025548 · Cited by 320 · see citing works

BCL-2: Prevention of Apoptosis as a Mechanism of Drug Resistance

Reed, J. C. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30104-7 · Cited by 312 · see citing works

A structural view of mitochondria-mediated apoptosis.

Shi, Y. (2001) · Nature Structural Biology · doi:10.1038/87548 · Cited by 307 · see citing works

A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells

Chiosis, G., Timaul, M. N., Lucas, B. S., Münster, P. N., Zheng, F. F., Sepp‐Lorenzino, L., & Rosen, N. X. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00015-1 · Cited by 289 · see citing works

Ribonucleotide reductases: amazing and confusing.

Stubbe, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39357-3 · Cited by 286 · see citing works

Inhibition of Protein−Protein Association by Small Molecules: Approaches and Progress

Toogood, P. L. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010468s · Cited by 281 · see citing works

Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53

Stoll, R., Renner, C., Hansen, S., Palme, S., Klein, C., Belling, A., Żesławski, W., Kamionka, M., Rehm, T., Mühlhahn, P., et al. (2000) · Biochemistry · doi:10.1021/bi000930v · Cited by 275 · see citing works

Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo

Silletti, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011343298 · Cited by 262 · see citing works

Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis

Haggarty, S. J., Mayer, T. U., Miyamoto, D. T., Fathi, R., King, R. W., Mitchison, T. J., & Schreiber, S. L. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00101-0 · Cited by 251 · see citing works

Molecular characterization of the hdm2-p53 interaction 1 1Edited by J. Karn

Böttger, A., Böttger, V., Garcı́a-Echeverrı́a, C., Chêne, P., Hochkeppel, H. K., Sampson, W. R., Ang, K. H., Howard, S. F., Picksley, S. M., & Lane, D. P. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1078 · Cited by 251 · see citing works

Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a

Finch, A. M., Wong, A. K., Paczkowski, N. J., Wadi, S. K., Craik, D. J., Fairlie, D. P., & Taylor, S. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9806594 · Cited by 247 · see citing works

Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication

Pari, G. S., & Anders, D. G. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.6979-6988.1993 · Cited by 238 · see citing works

Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptides.

Picksley, S. M., Vojtĕsek, B., Sparks, A., & Lane, D. P. (1994) · PubMed · Cited by 238 · see citing works

Antagonists of protein–protein interactions

Cochran, A. G. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00106-x · Cited by 228 · see citing works

Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant

GOLDSTEIN, D. J., & Weller, S. K. (1988) · Virology · doi:10.1016/0042-6822(88)90144-4 · Cited by 227 · see citing works

The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist

Duncia, J. V., Carini, D. J., Chiu, A. T., et al. (1992) · Medicinal Research Reviews · doi:10.1002/med.2610120203 · Cited by 214 · see citing works

The herpes simplex virus type 1 UL42 gene product: a subunit of DNA polymerase that functions to increase processivity

Gottlieb, J., Marcy, A. I., Coen, D. M., & Challberg, M. D. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.5976-5987.1990 · Cited by 213 · see citing works

Tryprostatin A, a specific and novel inhibitor of microtubule assembly

Usui, T., Kondoh, M., Cui, C., et al. (1998) · Biochemical Journal · doi:10.1042/bj3330543 · Cited by 212 · see citing works

Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides

Dutia, B. M., Frame, M. C., Subak-Sharpe, J. H., Clark, W. N., & Marsden, H. S. (1986) · Nature · doi:10.1038/321439a0 · Cited by 202 · see citing works

Bcl-2 family proteins as targets for anticancer drug design

Huang, Z. (2000) · Oncogene · doi:10.1038/sj.onc.1204087 · Cited by 201 · see citing works

Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry

McMillan, K., Adler, M., Auld, D. S., Baldwin, J. J., Blasko, E., Browne, L. J., Chelsky, D., Davey, D. D., Dolle, R. E., Eagen, K. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1506 · Cited by 200 · see citing works

Protein‐protein interactions as a target for drugs in proteomics

Archakov, A. I., Govorun, V. M., Dubanov, A. V., Ivanov, Y. D., Veselovsky, A. V., Lewi, P. J., & Janssen, P. (2003) · PROTEOMICS · doi:10.1002/pmic.200390053 · Cited by 194 · see citing works

Novel Peptides Selected to Bind Vascular Endothelial Growth Factor Target the Receptor-Binding Site

Fairbrother, W. J., Christinger, H. W., Cochran, A. G., Fuh, G., Keenan, C. J., Quan, C. L., Shriver, S. K., Tom, J., Wells, J. A., & Cunningham, B. C. (1998) · Biochemistry · doi:10.1021/bi981931e · Cited by 191 · see citing works

The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.

Dougall, W. C., Qian, X., Peterson, N. C., Miller, M. J., Samanta, A., & Greene, M. I. (1994) · PubMed · Cited by 180 · see citing works

Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2

Cohen, É. A., Gaudreau, P., Brazeau, P., et al. (1986) · Nature · doi:10.1038/321441a0 · Cited by 173 · see citing works

Generation of an LFA-1 Antagonist by the Transfer of the ICAM-1 Immunoregulatory Epitope to a Small Molecule

Gadek, T. R., Burdick, D. J., McDowell, R. S., Stanley, M. S., Marsters, J. C., Paris, K. J., Oare, D. A., Reynolds, M. E., Ladner, C., Zioncheck, K., et al. (2002) · Science · doi:10.1126/science.295.5557.1086 · Cited by 172 · see citing works

Isolation and Structure Elucidation of Chlorofusin, a Novel p53-MDM2 Antagonist from a Fusarium sp.

Duncan, S. J., Grüschow, S., Williams, D. H., McNicholas, C., Purewal, R., Hájek, M., Gerlitz, M., Martin, S., Wrigley, S. K., & Moore, M. (2001) · Journal of the American Chemical Society · doi:10.1021/ja002940p · Cited by 171 · see citing works

Localization of the Vinblastine-binding Site on β-Tubulin

Rai, S. S., & Wolff, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14707 · Cited by 166 · see citing works

Glycan-dependent and -independent Association of Vesicular Stomatitis Virus G Protein with Calnexin

Cannon, K. S., Hebert, D. N., & Helenius, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14280 · Cited by 163 · see citing works

Potent Peptide Analogues of a G Protein Receptor-binding Region Obtained with a Combinatorial Library

Martin, E. L., Rens‐Domiano, S., Schatz, P. J., & Hamm, H. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.361 · Cited by 155 · see citing works

The Crystal Structure of an Unusual Processivity Factor, Herpes Simplex Virus UL42, Bound to the C Terminus of Its Cognate Polymerase

Zuccola, H. J., Filman, D. J., Coen, D. M., & Hogle, J. M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80422-0 · Cited by 151 · see citing works

Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide

Zhang, Z., Poorman, R. A., Maggiora, L. L., Heinrikson, R. L., & Kézdy, F. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98445-0 · Cited by 150 · see citing works

Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis

Pari, G. S., Kacica, M. A., & Anders, D. G. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2575-2582.1993 · Cited by 142 · see citing works

Arrestin-rhodopsin interaction. Multi-site binding delineated by peptide inhibition.

Krupnick, J., Gurevich, V. V., Schepers, T. M., Hamm, H. E., & Benovic, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41852-7 · Cited by 135 · see citing works

Ribonucleotide Reductase Activity of Synchronized KB Cells Infected with Herpes Simplex Virus

Cohen, G. H. (1972) · Journal of Virology · doi:10.1128/jvi.9.3.408-418.1972 · Cited by 135 · see citing works

A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo

Liuzzi, M., Déziel, R., Moss, N., Beaulieu, P. L., Bonneau, A.-M., Bousquet, C., Chafouleas, J. G., Garneau, M., Jaramillo, J., Krogsrud, R. L., et al. (1994) · Nature · doi:10.1038/372695a0 · Cited by 131 · see citing works

Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2

Tilley, J., Chen, L., Fry, D. C., Emerson, S. D., Powers, G. D., Biondi, D. A., Varnell, T. A., Trilles, R. V., Guthrie, R. W., Mennona, F. A., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja970702x · Cited by 129 · see citing works

A Common Binding Site Mediates Heterodimerization and Homodimerization of Bcl-2 Family Members

Díaz, J.-L., Oltersdorf, T., Horne, W. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11350 · Cited by 129 · see citing works

A yeast genetic system for selecting small molecule inhibitors of protein–protein interactions in nanodroplets

Huang, J., & Schreiber, S. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13396 · Cited by 129 · see citing works

Identification of a High-Affinity Phosphopeptide Inhibitor of Stat3

Ren, Z., Cabell, L. A., Schaefer, T. S., & McMurray, J. S. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01050-8 · Cited by 128 · see citing works

Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Cardiovascular Disease

Vorchheimer, D. A. (1999) · JAMA · doi:10.1001/jama.281.15.1407 · Cited by 124 · see citing works

Agonists and antagonists of protein kinase C function, derived from its binding proteins.

Ron, D., & Mochly‐Rosen, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31814-8 · Cited by 123 · see citing works

Ribonucleotide Reductase Induced by Herpes Simplex Virus has a Virus-specified Constituent

Dutia, B. M. (1983) · Journal of General Virology · doi:10.1099/0022-1317-64-3-513 · Cited by 123 · see citing works

Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells

Ertl, P. F., & Powell, K. L. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4126-4133.1992 · Cited by 122 · see citing works

Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions

Imai, Y., Moralez, A., Andag, U., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000070200 · Cited by 121 · see citing works

Small molecule antagonists of proteins

Gadek, T. R., & Nicholas, J. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01479-x · Cited by 119 · see citing works

Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen

Young, K. H., Lin, S., Sun, L. R., et al. (1998) · Nature Biotechnology · doi:10.1038/nbt1098-946 · Cited by 113 · see citing works

Inhibiting the assembly of protein—protein interfaces

Zutshi, R., Brickner, M., & Chmielewski, J. A. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80036-7 · Cited by 110 · see citing works

High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.

Yanofsky, S. D., Baldwin, D. N., Butler, J. H., Holden, F., Jacobs, J. W., Balasubramanian, P., Chinn, J. P., Cwirla, S. E., Peters-Bhatt, E., Whitehorn, E. A., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7381 · Cited by 110 · see citing works

Angiotensin II Receptor Antagonists: An Emerging New Class of Cardiovascular Therapeutics.

Timmermans, P. B. M. W. M. (1999) · Hypertension Research · doi:10.1291/hypres.22.147 · Cited by 108 · see citing works

Characterization of Antiallodynic Actions of ALE-0540, a Novel Nerve Growth Factor Receptor Antagonist, in the Rat

Owolabi, J. B., Rizkalla, G., Tehim, A., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38269-2 · Cited by 105 · see citing works

A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats

Strachan, A. J., Woodruff, T. M., Haaima, G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6560 · Cited by 103 · see citing works

Characterization of p53 oligomerization domain mutations isolated from Li–Fraumeni and Li–Fraumeni like family members

Lomax, M. E., Barnes, D. M., Hupp, T. R., Picksley, S. M., & Camplejohn, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201974 · Cited by 100 · see citing works

From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione Scaffold

McDowell, R. S., Blackburn, B. K., Gadek, T. R., et al. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00091a008 · Cited by 99 · see citing works

Transducible Peptide Therapy for Uveal Melanoma and Retinoblastoma

Harbour, J. W. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.10.1341 · Cited by 98 · see citing works

Potent Blockade of Hepatocyte Growth Factor-stimulated Cell Motility, Matrix Invasion and Branching Morphogenesis by Antagonists of Grb2 Src Homology 2 Domain Interactions

Atabey, N., Gao, Y., Yao, Z., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010202200 · Cited by 96 · see citing works

Synthetic “interface” peptides alter dimeric assembly of the HIV 1 and 2 proteases

Babé, L. M., Rosé, J., & Craik, C. S. (1992) · Protein Science · doi:10.1002/pro.5560011003 · Cited by 94 · see citing works

Disabling Receptor Ensembles with Rationally Designed Interface Peptidomimetics

Berezov, A., Chen, J., Liu, Q., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202880200 · Cited by 93 · see citing works

The essential 65-kilodalton DNA-binding protein of herpes simplex virus stimulates the virus-encoded DNA polymerase

Gallo, M., Dorsky, D. I., Crumpacker, C. S., et al. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5023-5029.1989 · Cited by 91 · see citing works

Molecular Mimics of Insulin-like Growth Factor 1 (IGF-1) for Inhibiting IGF-1: IGF-Binding Protein Interactions

Lowman, H. B., Chen, Y. M., Skelton, N. J., Mortensen, D. L., Tomlinson, E. E., Sadick, M. D., Robinson, I. C. A. F., & CLARK, R. G. (1998) · Biochemistry · doi:10.1021/bi980426e · Cited by 89 · see citing works

F2 (Pmp)2 -TAM ζ3 , a Novel Competitive Inhibitor of the Binding of ZAP-70 to the T Cell Antigen Receptor, Blocks Early T Cell Signaling

Wange, R. L., Isakov, N., Burke, T. R., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.944 · Cited by 86 · see citing works

Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307).

Wong, P. C., Chiu, A. T., Price, W. A., et al. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)19967-9 · Cited by 85 · see citing works

Peptide Ligands to Human Immunodeficiency Virus Type 1 gp120 Identified from Phage Display Libraries

Ferrer, M., & Harrison, S. C. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5795-5802.1999 · Cited by 85 · see citing works

The extreme C terminus of herpes simplex virus DNA polymerase is crucial for functional interaction with processivity factor UL42 and for viral replication

Digard, P., Bebrin, W. R., Weißhart, K., et al. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.398-406.1993 · Cited by 83 · see citing works

Potent α4β1 Peptide Antagonists as Potential Anti-Inflammatory Agents

Jackson, D. Y., Quan, C. L., Artis, D. R., Rawson, T. E., Blackburn, B. K., Struble, M. E., Fitzgerald, G. M., Chan, K. S., Mullins, S., Burnier, J. P., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970175s · Cited by 80 · see citing works

Protein–protein interactions as targets for antiviral chemotherapy

Loregian, A., Marsden, H. S., & Palù, G. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.356 · Cited by 79 · see citing works

Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain.

Divita, G., Restle, T., Goody, R. S., Chermann, J., & Baillon, J. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36800-x · Cited by 78 · see citing works

Structural studies of potent constrained RGD peptides

McDowell, R. S., & Gadek, T. R. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00050a001 · Cited by 77 · see citing works

Minimized proteins

Cunningham, B. C., & Wells, J. A. (1997) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(97)80107-8 · Cited by 77 · see citing works

Residues of Human Cytomegalovirus DNA Polymerase Catalytic Subunit UL54 That Are Necessary and Sufficient for Interaction with the Accessory Protein UL44

Loregian, A., Appleton, B. A., Hogle, J. M., et al. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.158-167.2004 · Cited by 76 · see citing works

A New Potent HIV-1 Reverse Transcriptase Inhibitor

Morris, M. C., Robert-Hebmann, V., Chaloin, L., Méry, J., Heitz, F., Devaux, C. A., Goody, R. S., & Divita, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24941 · Cited by 71 · see citing works

Design and synthesis of a CD4 beta-turn mimetic that inhibits human immunodeficiency virus envelope glycoprotein gp120 binding and infection of human lymphocytes.

Chen, S., Chrusciel, R. A., Nakanishi, H., et al. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5872 · Cited by 69 · see citing works

Characterization of the Dimer Interface of Transcription Factor NFκB p50 Homodimer

Sengchanthalangsy, L. L., Datta, S., Huang, D.-B., Anderson, E., Braswell, E. H., & Ghosh, G. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2823 · Cited by 67 · see citing works

Crystal Structure of the Complex between VEGF and a Receptor-Blocking Peptide

Wiesmann, C., Christinger, H. W., Cochran, A. G., et al. (1998) · Biochemistry · doi:10.1021/bi9819327 · Cited by 65 · see citing works

Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation

McClements, W. L., Yamanaka, G. A., Garsky, V. M., et al. (1988) · Virology · doi:10.1016/0042-6822(88)90421-7 · Cited by 65 · see citing works

Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene

Ripalti, A., Boccuni, M. C., Campanini, F., et al. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2047-2057.1995 · Cited by 65 · see citing works

The Carboxyl Terminus of the γ-Subunit of Rod cGMP Phosphodiesterase Contains Distinct Sites of Interaction with the Enzyme Catalytic Subunits and the α-Subunit of Transducin

Skiba, N. P., Artemyev, N. O., & Hamm, H. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13210 · Cited by 63 · see citing works

Specific Residues in the Connector Loop of the Human Cytomegalovirus DNA Polymerase Accessory Protein UL44 Are Crucial for Interaction with the UL54 Catalytic Subunit

Loregian, A., Appleton, B. A., Hogle, J. M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9084-9092.2004 · Cited by 62 · see citing works

Functional analysis of the herpes simplex virus UL42 protein

Digard, P., Chow, C. S., Pirrit, L. A., et al. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1159-1168.1993 · Cited by 61 · see citing works

Correction: A new potent HIV-1 reverse transcriptase inhibitor: A synthetic peptide derived from the interface subunit domains.

Morris, M. C., Méry, J., Heitz, F., Goody, R. S., & Divita, G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aac119.008640 · Cited by 61 · see citing works

Inhibition by trifluoperazine of calmodulin-induced activation of ATPase activity of rat erythrocyte

Levin, R. M., & Weiss, B. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90134-3 · Cited by 61 · see citing works

Structure-based Design of Compounds Inhibiting Grb2-SH2 Mediated Protein-protein Interactions in Signal Transduction Pathways

Fretz, H., Furet, P., Garcı́a-Echeverrı́a, C., et al. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003398546 · Cited by 61 · see citing works

Inhibition of HIV-1 Protease by a Subunit of Didemnaketal A

Fan, X., Flentke, G. R., & Rich, D. H. (1998) · Journal of the American Chemical Society · doi:10.1021/ja981306x · Cited by 57 · see citing works

A Synthetic Peptide from the Human Immunodeficiency Virus Type‐1 Integrase Exhibits Coiled‐Coil Properties and Interferes with the in Vitro Integration Activity of The Enzyme

Sourgen, F., Maroun, R. G., Frère, V., Bouziane, M., Auclair, C., Troalen, F., & Fermandjian, S. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0765h.x · Cited by 56 · see citing works

Tyrosine 50 at the Subunit Interface of Dimeric Human Glutathione Transferase P1-1 Is a Structural Key Residue for Modulating Protein Stability and Catalytic Function

Stenberg, G., Abdalla, A.-M., & Mannervik, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2579 · Cited by 56 · see citing works

Binding of an inhibitor of the p53/MDM2 Interaction to MDM2

Duncan, S. J., Cooper, M. A., & Williams, D. H. (2003) · Chemical Communications · doi:10.1039/b211889k · Cited by 56 · see citing works

Specific inhibition of herpes simplex virus DNA polymerase by helical peptides corresponding to the subunit interface.

Digard, P., Williams, K. P., Hensley, P., Brooks, I. S., Dahl, C. E., & Coen, D. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1456 · Cited by 55 · see citing works

Identification of a Novel Class of Small-Molecule Antiangiogenic Agents through the Screening of Combinatorial Libraries Which Function by Inhibiting the Binding and Localization of Proteinase MMP2 to Integrin α V β 3

Boger, D. L., Goldberg, J., Silletti, S., et al. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003579+ · Cited by 55 · see citing works

Synthesis and SAR of N-Benzoyl-?-Biphenylalanine Derivatives: Discovery of TR-14035, A Dual α4β7/α4β1 Integrin Antagonist

Sircar, I. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00021-4 · Cited by 55 · see citing works

Inhibition of Human Cytomegalovirus DNA Polymerase by C-Terminal Peptides from the UL54 Subunit

Loregian, A., Rigatti, R., Murphy, M., Schievano, E., Palù, G., & Marsden, H. S. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8336-8344.2003 · Cited by 53 · see citing works

Synthetic peptides as inactivators of multimeric enzymes: inhibition of Plasmodium falciparum triosephosphate isomerase by interface peptides

Singh, S. K., Maithal, K., Balaram, H., et al. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02606-0 · Cited by 53 · see citing works

Design, Synthesis, and Evaluation of Conformationally Constrained Tongs, New Inhibitors of HIV-1 Protease Dimerization

Bouras, A., Boggetto, N., Benatalah, Z., de Rosny, E., Sicsic, S., & Reboud‐Ravaux, M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9803976 · Cited by 51 · see citing works

Identification of a Small Molecule that Inhibits Herpes Simplex Virus DNA Polymerase Subunit Interactions and Viral Replication

Pilger, B., Cui, C., & Coen, D. M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.01.018 · Cited by 51 · see citing works

Rational design of a GCN4-derived mimetic of interleukin-4.

Oschkinat, H., Serrano, L. G., Domingues, H., Cregut, D., & Sebald, W. (1999) · Nature Structural Biology · doi:10.1038/10706 · Cited by 50 · see citing works

Mechanism of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. Specific binding of a photoaffinity analog, [4′- azido-Phe6] HSV H2-6(6-15), to subunit 1.

Paradis, H., Gaudreau, P., Brazeau, P., et al. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37554-9 · Cited by 47 · see citing works

Antiviral Activity of a Selective Ribonucleotide Reductase Inhibitor against Acyclovir-Resistant Herpes Simplex Virus Type 1 In Vivo

Duan, J., Liuzzi, M., Paris, W., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1629 · Cited by 46 · see citing works

Sequences at the C-terminus of the herpes simplex virus type 1 UL30 protein are dispensable for DNA polymerase activity but not for viral origin-dependent DNA replication

Stow, N. D. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.1.87 · Cited by 45 · see citing works

Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin

Loregian, A., Papini, E., Satin, B., Marsden, H. S., Hirst, T. R., & Palù, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5221 · Cited by 42 · see citing works

Role of the Carboxy Terminus of Herpes Simplex Virus Type 1 DNA Polymerase in its Interaction With UL42

Marsden, H. S., Murphy, M., McVey, G. L., MacEachran, K. A., Owsianka, A. M., & Stow, N. D. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-11-3127 · Cited by 42 · see citing works

Integrins and Disease

Hillis, G. S., & MacLeod, A. M. (1996) · Clinical Science · doi:10.1042/cs0910639 · Cited by 41 · see citing works

Denaturation and Reactivation of Dimeric Human Glutathione Reductase

Nordhoff, A., Tziatzios, C., Broek, J. A. V. D., Schott, M. K., Kalbitzer, H. R., Becker, K., Schubert, D., & Schirmer, R. H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00273.x · Cited by 39 · see citing works

Equilibrium and Kinetic Study of the Conformational Transition toward the Active State of p21Ha-, Induced by the Binding of BeF3− to the GDP-bound State, in the Absence of GTPase-activating Proteins

Díaz, J. F., Sillen, A., & Engelborghs, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23138 · Cited by 39 · see citing works

Mutations in the C terminus of herpes simplex virus type 1 DNA polymerase can affect binding and stimulation by its accessory protein UL42 without affecting basal polymerase activity

Tenney, D. J., Micheletti, P. A., Stevens, J. T., et al. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.543-547.1993 · Cited by 38 · see citing works

Peptidomimetic Inhibitors of Herpes Simplex Virus Ribonucleotide Reductase with Improved in Vivo Antiviral Activity

Moss, N., Beaulieu, P. L., Duceppe, J., Ferland, J., Garneau, M., Gauthier, J. B., Ghiro, É., Goulet, S., Guse, I., Jaramillo, J., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960324r · Cited by 36 · see citing works

Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives

Moss, N., Déziel, R., Adams, J. D., et al. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00072a021 · Cited by 35 · see citing works

Design and synthesis of new inhibitors of HIV-1 protease dimerization with conformationally constrained templates

Myeong-cheol, S., Rajesh, S., Hayashi, Y., & Kiso, Y. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00468-1 · Cited by 35 · see citing works

Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease

Brandt, C. R., Spencer, B. J., Imesch, P. D., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1078 · Cited by 33 · see citing works

Identification of Crucial Hydrogen-Bonding Residues for the Interaction of Herpes Simplex Virus DNA Polymerase Subunits via Peptide Display, Mutational, and Calorimetric Approaches

Bridges, K. G., Chow, C. S., & Coen, D. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.4990-4998.2001 · Cited by 31 · see citing works

High level expression of DNA polymerases from herpesviruses

Ertl, P. F., Thomas, M. S., & Powell, K. L. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-7-1729 · Cited by 30 · see citing works

The herpes simplex virus type 1 DNA polymerase accessory protein, UL42, contains a functional protease-resistant domain

Hamatake, R. K., Bifano, M., Tenney, D. J., et al. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-10-2181 · Cited by 30 · see citing works

Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents

Moss, N., Beaulieu, P. L., Duceppe, J., Ferland, J., Gauthier, J. B., Ghiro, E., Goulet, S., Grenier, L., Llinàs‐Brunet, M., Plante, R., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00018a022 · Cited by 29 · see citing works

Identification of Hydrophobic Amino Acid Residues Involved in the Formation of S100P Homodimers in Vivo

Koltzscher, M., & Gerke, V. (2000) · Biochemistry · doi:10.1021/bi000257+ · Cited by 28 · see citing works

Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit.

Marcello, A., Loregian, A., CROSS, A. M., Marsden, H. S., Hirst, T. R., & Palù, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8994 · Cited by 28 · see citing works

Restricting the flexibility of crosslinked, interfacial peptide inhibitors of HIV-1 protease

Ulysse, L. G., & Chmielewski, J. A. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00595-2 · Cited by 25 · see citing works

Conformational aspects of HIV-1 integrase inhibition by a peptide derived from the enzyme central domain and by antibodies raised against this peptide.

Maroun, R., Krebs, D., Roshani, M., Porumb, H., Auclair, C., Troalen, F., & Fermandjian, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00130.x · Cited by 25 · see citing works

Structure-Based Design of Novel Anticancer Agents

Uckun, F. M., Sudbeck, E. A., Mao, C., et al. (2001) · Current Cancer Drug Targets · doi:10.2174/1568009013334287 · Cited by 25 · see citing works

Efalizumab

Marecki, S., & Kirkpatrick, P. N. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1420 · Cited by 23 · see citing works

A Leucine Zipper-Like Domain Is Essential for Dimerization and Encapsidation of Bluetongue Virus Nucleocapsid Protein VP4

Ramadevi, N., Rodríguez, J. M., & Roy, P. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2983-2990.1998 · Cited by 22 · see citing works

Inhibitors of protein-protein interactions

Gadek, T. R., & Ockey, D. A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.3.393 · Cited by 22 · see citing works

Interaction of the Capsid Protein p24 (HIV-1) with Sequence-Derived Peptides: Influence on p24 Dimerization

Hilpert, K., Behlke, J., Scholz, C., et al. (1999) · Virology · doi:10.1006/viro.1998.9526 · Cited by 22 · see citing works

Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonist with efficacy in a restenosis model

Keenan, R. M., Lago, M. A., Miller, W. H., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00556-3 · Cited by 21 · see citing works

Characterization of novel calmodulin-binding peptides with distinct inhibitory effects on calmodulin-dependent enzymes

NEVALAINEN, L. T., Aoyama, T., Ikura, M., et al. (1997) · Biochemical Journal · doi:10.1042/bj3210107 · Cited by 20 · see citing works

Inhibiting Protein−Protein Interactions: A Model for Antagonist Design

Chrunyk, B. A., Rosner, M. H., Cong, Y., et al. (2000) · Biochemistry · doi:10.1021/bi000096+ · Cited by 19 · see citing works

Novel H3 receptor antagonists. Sulfonamide homologs of histamine

Wolin, R. L., Connolly, M., Afonso, A., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00379-5 · Cited by 18 · see citing works

Preventing estrogen receptor action with dimer-interface peptides

Yudt, M. R., & Koide, S. (2001) · Steroids · doi:10.1016/s0039-128x(00)00224-5 · Cited by 15 · see citing works

Design of Peptidomimetics That Inhibit the Association of Phosphatidylinositol 3-Kinase with Platelet-Derived Growth Factor-β Receptor and Possess Cellular Activity

Eaton, S. R., Cody, W. L., Doherty, A. M., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9802766 · Cited by 15 · see citing works

Angiotensin II antagonists—saralasin

Moore, A. F., & Fulton, R. W. (1984) · Drug Development Research · doi:10.1002/ddr.430040309 · Cited by 14 · see citing works

Ureido-Based Peptidomimetic Inhibitors of Herpes Simplex Virus Ribonucleotide Reductase: An Investigation of Inhibitor Bioactive Conformation

Moss, N., Beaulieu, P. L., Duceppe, J., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950825x · Cited by 14 · see citing works

Nonpeptidic, Monocharged, Cell Permeable Ligands for the p56lck SH2 Domain

Proudfoot, J., Betageri, R., Cardozo, M. G., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000446q · Cited by 13 · see citing works

Hormonal strategies for breast cancer: a new focus on the estrogen receptor as a therapeutic target.

Jordan, V. C., Jeng, M. H., Jiang, S. Y., et al. (1992) · PubMed · Cited by 13 · see citing works

Design and synthesis of small molecule interleukin-1 receptor antagonists based on a benzene template.

Sarabu, R., Cooper, J. P., Cook, C. M., et al. (1998) · PubMed · Cited by 13 · see citing works

Single Amino Acid Substitutions Disrupt Tetramer Formation in the Dihydroneopterin Aldolase Enzyme of Pneumocystis carinii

Thomas, M. C., Ballantine, S. P., Bethell, S. S., et al. (1998) · Biochemistry · doi:10.1021/bi980540x · Cited by 12 · see citing works

Modulation of Dimerization, Binding, Stability, and Folding by Mutation of the Neurophysin Subunit Interface

Eubanks, S., Nguyen, T. L., Peyton, D. H., et al. (2000) · Biochemistry · doi:10.1021/bi0001527 · Cited by 6 · see citing works

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes?

Camarasa, M.-J., Velázquez, S., San-Félix, A., Pérez-Pérez, M.-J., & Gago, F. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.021 · Cited by 66 · see citing works

Targeting protein–protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?

Cierpicki, T., & Grembecka, J. (2015) · Immunological Reviews · doi:10.1111/imr.12244 · Cited by 53 · see citing works

Druggable Orthosteric and Allosteric Hot Spots to Target Protein-protein Interactions

Ma, B., & Nussinov, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990073 · Cited by 45 · see citing works

Systematic investigation of machine learning on limited data: A study on predicting protein-protein binding strength

Zheng, F., Jiang, X., Wen, Y., Yang, Y., & Li, M. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.12.018 · Cited by 14 · see citing works

Protein–protein interactions as targets for small-molecule therapeutics in cancer

White, A. W., Westwell, A. D., & Brahemi, G. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000641 · Cited by 122 · see citing works

Design of small molecules targeting RNA structure from sequence

Ursu, A., Childs‐Disney, J. L., Andrews, R. J., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00455c · Cited by 76 · see citing works

In search of small molecules blocking interactions between HIV proteins and intracellularcofactors

Busschots, K., Rijck, J. D., Christ, F., & Debyser, Z. (2008) · Molecular BioSystems · doi:10.1039/b810306b · Cited by 34 · see citing works

Targeting RNA structures with small molecules

Childs‐Disney, J. L., Yang, X., Gibaut, Q. M. R., Tong, Y., Batey, R., & Disney, M. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00521-4 · Cited by 599 · see citing works

A Combined Experimental and Computational Strategy to Define Protein Interaction Networks for Peptide Recognition Modules

Tong, A. H. Y., Drees, B., Nardelli, G., Bader, G. D., Brannetti, B., Castagnoli, L., Evangelista, M., Ferracuti, S., Nelson, B., Paoluzi, S., et al. (2002) · Science · doi:10.1126/science.1064987 · Cited by 692 · see citing works